Navigation Links
Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable Genotypes
Date:9/22/2008

Common Genetic Variations Predict Patient Response to Novel Beta Blocker

Therapy

TORONTO, Sept. 22 /PRNewswire/ -- Bucindolol, an investigational, pharmacologically unique beta-blocker and mild vasodilator, significantly reduces hospitalization and death among heart failure patients with very favorable genotypes, according to results of a large DNA study presented today as a poster at the annual meeting of the Heart Failure Society of America. Researchers found that common genetic variations can predict which heart failure patients will have the greatest therapeutic response to bucindolol.

ARCA biopharma has submitted a New Drug Application (NDA) for bucindolol to the U.S. Food and Drug Administration for the treatment of chronic heart failure.

"The ability to predict patient response to bucindolol makes it easier for physicians to match the right patient to the right medicine, potentially avoiding months of trial-and-error therapy and helping very sick heart failure patients achieve better outcomes sooner," said Christopher O'Connor, M.D., Director of the Heart Center at Duke University Medical Center and presenter of the study. "This data brings us much closer to realizing the benefits of personalized medicine in heart failure."

The prospectively-designed DNA sub-study included more than 1,000 patients enrolled in the Beta-Blocker Evaluation of Survival Trial (BEST), the largest heart failure mortality trial conducted primarily in the United States. Researchers evaluated therapeutic response to bucindolol among patients with genetic variations, or polymorphisms, in two adrenergic receptors that help regulate cardiac function: beta 1 389 Arg/Gly and alpha 2c 322-325 WT/Del. Researchers identified three distinct genotypes that predict the effect of bucindolol: very favorable (47% of BEST patients), favorable (40%) and unfavorable (13%).

In the study, patients with the very favorable genotype
'/>"/>

SOURCE ARCA biopharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
2. Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
3. Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
4. UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
5. New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
6. Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer
7. Cord Blood America CEO Matthew Schissler Says Operations Significantly Streamlined
8. Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
9. Phase 3 studies show golimumab significantly improved signs and symptoms of rheumatoid arthritis
10. On the boil: New nano technique significantly boosts boiling efficiency
11. Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2009)...eam of researchers has modified chlorophyll from a...t light antennae of bacteria. The team was then ab...nae. This is the first step to converting sunlight...hers will be publishing an article on their resear...AS journal in the week starting 29 June. Leiden r...
(Date:6/30/2009)... VEGA PROMOTIONAL SYSTEMS...chosen Chattanooga, TN based consulting firm, Tenn... building a biomass production facility in Georgia...o build a biomass plant in Georgia to take advanta...ate,s Bioenergy Corridor. Georgia ranks third in ...
(Date:6/30/2009)...009 Earnings Conference Call Tuesday, August 4, 20...ne 30 Cephalon, Inc. (Na... earnings conference call covering second quarter ...4, 2009. , , August 4, 2009 Schedule , ,...buted by PRNewswire, 4:50 p.m. EDT To partic...
(Date:6/30/2009)...Ocean Lala sailed from the Taichung Harbor to Xiam...crew members - , , CITY OF INDUSTRY, Calif. a...T BioTech Holdings, Inc. (Pink Sheets: EFTB) annou...r International Marine Corporation, completed its ...t on June 28, 2009. The voyage across the Taiwan ...
Breaking Biology Technology:First step to converting solar energy using 'artificial leaf' 2Vega Picks Tennessee Firm to Assist with Construction of Biomass Plant in Georgia 2EFT BioTech Holdings, Inc.'s Sea Vessel Completes Inaugural Passenger Voyage Across the Taiwan Strait 2EFT BioTech Holdings, Inc.'s Sea Vessel Completes Inaugural Passenger Voyage Across the Taiwan Strait 3
A small Madison biotech firm, EraGen Biosciences, has just forged a worldwide distribution conduit for one of its products. The firm exclusively licensed rights to its test for cystic fibrosis, a gen
...alified 10 more businesses for investor tax credit... research and development firms to get up to 25 pe...t up to $3.5 million to venture capitalists and $3... It,s up to the business to sign up and to qualify...ork. , ,Investors say that the credits rarely make...
...tarting up a new Lake Superior chapter in Ashland ...isconsin. , ,WIN organizes networking events, semi...he Wisconsin Technology Council , a state-funded ...hnology policy. , ,Other chapters exist in Madison...y. , ,Lake Superior chapter organizers include for...
...in-Madison are taking another look at some long-he...fect. That,s what scientists call the way sounds c... highway, for example, a jackhammer or a siren wil...fter you drive past. , ,But there,s an inverse D...st observed in 2003 by British scientists. UW-Madi...
Other Biology Technology:
(Date:7/2/2009)...N-SALEM, N.C. New research out of Wake Forest Uni...time a solid scientific answer for the long-standi...ween preterm birth and brain malformations. , I...ies, researchers found that there is a strong asso...rm birth, leading investigators to believe that so...
(Date:7/2/2009)...release is available in German . , , A good w...rel. Even before the harvest, the grapevines have ...or rainy periods can destroy entire crops, not to ...on the scene. Bugs such as the vine louse or the r... the "Grapevine fanleaf virus" (GFLV for short) ca...
(Date:7/2/2009)...INIA KEY, Fla. As the nation celebrates its birth...essor Diego Lirman and fellow Caribbean coral reef...The National Oceanic and Atmospheric Administratio...cy and its partners, staghorn and elkhorn coral re...ayne National Park, will receive support from the ...
(Date:7/1/2009)...iously, only a few genes had been associated with ...Now, researchers of the Max Delbrck Center for Mol...ersity Medicine Berlin, Germany, have identified 1... tumor and in its metastases. In the future, their...ve tumors at an earlier stage ( Gastroenterology ...
Breaking Biology News(10 mins):Brain malformations significantly associated with preterm birth, Wake Forest research shows 2Brain malformations significantly associated with preterm birth, Wake Forest research shows 3Virus-resistant grapevines 2Nursery programs for corals receive TLC from NOAA this Independence Day 2Colorectal cancer 2CO2 drop and global cooling caused Antarctic glacier to form 7287 1CO2 drop and global cooling caused Antarctic glacier to form 7287 2Talk About Curing Autism Launches Seven New Chapters 37922 1Talk About Curing Autism Launches Seven New Chapters 37922 2Procter 26 Gamble Gives Back With GIVE Health 37920 1Procter 26 Gamble Gives Back With GIVE Health 37920 2Procter 26 Gamble Gives Back With GIVE Health 37920 3Scientists Discover Why Teeth Form in a Single Row 3927 1Scientists Discover Why Teeth Form in a Single Row 3927 2Scientists Discover Why Teeth Form in a Single Row 3927 3Scientists Discover Why Teeth Form in a Single Row 3927 4Scientists Discover Why Teeth Form in a Single Row 3927 5
...at may have broader implications for understanding...ldren,s Hospital of Philadelphia have identified a... a genetic developmental disease that affects mult...ly discovered the first gene associated with this ...n the NOTCH2 gene were linked to kidney abnormalit...
...ohns Hopkins Children,s Center scientists has iden...n that plays a key role in cystic fibrosis (CF), a...ability to transport chloride in and out of cells....in the laboratory, researchers successfully interc...prevented cell damage by the protein, effectively ...
...ion plays an important role in causing cancers via...ine the rules as to which segments of genetic mate...g researchers may be able to interrupt that proces...ors. Using yeast as a model organism, researchers ...ered that the location of a hairpin-capped break r...
...ye," said one 3 and a half-year old child, born de...ored hearing nine months earlier. That,s the most ...session that involved play with a toy train set. ...ochlear implant 31 months earlier made more sophis...and there with that noise and now -- Woo! Woo!" an...
Other Biology News:Gene discovery may shed light on kidney disease 2Johns Hopkins lab scientists tame overactive CF protein 2Scientists uncover rules for gene amplification 2With cochlear implants, earlier use leads to better speech 2With cochlear implants, earlier use leads to better speech 3
Rabbit polyclonal to MA2 ( Abpromise for all tested applications). entrezGeneID: 10687 SwissProtID: Q9UL42
Mouse monoclonal [YPF19] to Yersinia pestis ( Abpromise for all tested applications).
DDO Immunogen: DDO (NP_003640, 270 a.a. ~ 370 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only
Yersinia pestis
Biology Products: